Legal framework of TSE surveillance Workshop on Prevention, Control and Eradication of Transmissible Spongiform Encephalopathies (TSE) Serbian Ministry.

Slides:



Advertisements
Similar presentations
Scrapie FAQs. Q: What is scrapie? A: Scrapie is a fatal, degenerative disease affecting the central nervous system of sheep and goats. It is in the same.
Advertisements

Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.
Health and Consumers Health and Consumers Proposal for new EU Animal Health Regulation European Parliament, Intergroup on the welfare & conservation of.
Women on Boards in Europe – From a Snail’s Pace to a Giant Leap? EWL report on progress and gaps Seminar ‘Equal Rights, Equal Voices? Women in Decision-Making.
ASF in the EU Vilnius 09/12/14 This presentation does not necessarily represent the views of the European Commission.
Current status of the recognition of the clinical / medical genetics specialty Milan Macek Department of Biology and Medical Genetics Charles University.
Decision-making process in the Nikolay Kaveshnikov, Moscow State Institute of International Relations (University)
Bovine Spongiform Encephalopathy Luke VanNatter Carrie Pell Amy Richwine Scott Inskeep Kristina Anderson.
Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.
Reichstag, 1945 Frankfurter Allee, 1945 A Climate for Radical Change:
European integration 1www.ecb.europa.eu © Progress of European integration 1952ECSC European Coal and Steel Community 1958 EEC and EURATOM European Economic.
When was the European Union formed? About fifty years ago in Where was the European Union? Belgium, France, Germany, Italy, Luxembourg, and The.
Animal health and welfare monitoring as integrated part of meat inspection Conference on meat inspection A lberto Laddomada H ead o f U nit SANCO D1 Animal.
Introduction to Europe & European Law
Europe: A mid term PSI review Chris Corbin ePSIplus Analyst Den Haag, The Netherlands, funded by eContentPlus.
Case Study Comparing the V4 with the new EU(6) & EU(2) Cross border meeting - Visegrad Countries Chris Corbin ePSIplus Analyst Beckov, Slovakia, 11 th.
Canada’s BSE Story Presentation to the Ontario Association of Bovine Practitioners November 6, 2003.
EUROPEAN UNION. WHAT Coalition of 30 countries united in ECONOMY World’s largest trading bloc. World’s largest exporter to the world 16 TRILLION *Biggest.
Interim report of WG 5/6 subgroup: Review of Phase 2 NAPs Mark Johnson 22/02/07.
Geneticaly modified Food and Feed – current situation in EU Petr Beneš Food Safety Department Prague, 9 October 2009.
Assistant Professor Nicoleta SIRGHI Assistant Professor Ioana VADASAN 1.
BSE/TSE measures – state of play and future work Plenary of the Advisory Group on the Food Chain, Animal and Plant Health 19 December 2008.
January 2002 WHO/CSR/APH Efforts and needs for global control of BSE and vCJD Maura N. Ricketts MD MHSc FRCPC WHO/CDS/CSR/EPH.
BSE: World Situation and USDA Response FDA TSE Advisory Committee Silver Spring, MD October 14, 2004 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA,
1st Regional Workshop: Improving National and Regional Disease Surveillance, Monitoring and Reporting Systems Belgrade, Serbia, July 2013 FAO Technical.
Role-play on EU decision-making. The European Union: 500 million people – 28 countries Member states of the European Union Candidate and potential candidate.
State of play of OP negotiations and OP implementation ESF Technical Working Group Luxembourg, 2 December
Time line By: Shirley Lin. The story of European Union
BSE: World update FDA TSE Advisory Committee Gaithersburg, MD September 18, 2006 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS, Veterinary.
Microbes and Diseases Chapter 02. CREUTZFELDT-JAKOB DISEASE Prion.
The 19 th of June 1990 : The Schengen Implementing Convention has been signed by : - Germany - Belgium - France - Luxembourg - Netherlands Calendar.
David M. Asher, MD Division of Emerging & Transfusion-Transmitted Diseases Office of Blood Research & Review Center for Biologics Evaluation & Research.
Regional Workshop 2: Improving Capacity for Diagnosis of Fish and Mollusc Diseases Banja Luka, Bosnia and Herzegovina, October 2013, Hotel Palas.
AGR KIEV, 2 NOVEMBER 2010 Andrzej Chirkowski IDENTIFICATION, REGISTRATION AND TRACEABILITY: FROM FARM TO FORK.
INTEGRATED CONTROLS DIVISION Cross Compliance Farm Advisory Service Training 2016 SMR 5 ‘ Hormone Ban’
Self employed persons (SEP) Slovak Republic Budapest
National Veterinary Research & Quarantine Service NVRQS, MAF, Korea.
The development of slaughterhouse control measures for BSE Elvis Šturbej, DVM Kiev, 4 – 5 April 2011 Workshop on Bovine Spongiform Encephalopathy (BSE)
Official investigation on a case of BSE on the example of a EU member state I Ivan Ambrožič, DVM, MSc Kiev 4. – 5- April 2011.
Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Risk tissues. Destruction of specified risk material wastes in products not intended for human consumption Workshop on Bovine Spongiform Encephalopathy.
Import of equidae into EU EU legal base TAIEX Workshop AGR Moldova, 3-4 November 2014 DVM Hentriikka Kontio Ministry of Agriculture and Forestry,
European Innovation Scoreboard European Commission Enterprise and Industry DG EPG DGs meeting, May 2008.
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

EUROPEAN UNION – MAKING OFF European Economic Community
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION
Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
The European Parliament – voice of the people
The European Parliament – voice of the people
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
State of play of OP negotiations and OP implementation
Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014
Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
European Union Membership
Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,
New voting rules in Regulatory Committe
Regional Accounts ESA 95 Data Collection
Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Presentation transcript:

Legal framework of TSE surveillance Workshop on Prevention, Control and Eradication of Transmissible Spongiform Encephalopathies (TSE) Serbian Ministry of Agriculture – European Commission Belgrade 1-2 December 2014 Angel Ortiz Pelaez DVM MSc PhD

Contents Initial: legislation BSE Consolidation: notifiable diseases Integration: passive surveillance Integration: Reg. 999/2001/EC Amendments Summary

Initial legislation BSE Emergence of BSE in cattle in the UK in the late 80s Progressive enactment of measures in the EU: prevention and control via trade restrictions The first legislative act linked to TSE started in Ban of UK beef/live cattle (Decision 89/469/EEC): trade restrictions of certain live cattle from UK to the other MS, export of cattle born before July Ban of UK cattle products, specified risk material (SRM) (Decision 90/1990/EEC): brains, spinal cord, thymus, tonsils, spleen, intestines derived from bovine animals aged more than six months at slaughter.

Consolidation: BSE as notifiable disease First indigenous case of BSE (OIE) 1986: UK 1989: Ireland, NI 1990: Switzerland 1991: France 1994: Portugal 1997: Belgium, Luxembourg, Netherlands, 1998: Lichtenstein 2000: Denmark, Germany, Spain 2001: Austria, Czech Rep., Finland, Greece, Italy, Slovakia, Slovenia, 2002: Poland 2006: Sweden 2014: Romania All outbreaks of BSE must be notified (Decision 90/134/EEC) Differentiation between surveillance and control: Passive surveillance SRM and trade restrictions Commission Decision 96/385/EC approved the UK’s plan for the eradication of BSE Passive surveillance insufficient to describe epidemiological situation

Consolidation: Scrapie as notifiable disease Present in sheep population for +350 years Most of European countries had national legislation before 1991 Scrapie compulsorily notifiable disease in all MSs (Directive 91/68/EEC) Year Scrapie became notifiable 1970: Sweden 1974: Romania 1980: Finland 1987: Cyprus 1988: Denmark 1990: Luxemburg, Belgium 1991: Italy 1993: UK, Netherlands 1996: Portugal 1997: France, Greece

Integrating TSE passive surveillance Epidemio-surveillance of TSE (Decision 98/272/EC) Requirements for the detection of both BSE in cattle and scrapie in ovine and caprine animals. –Awareness for vets, breeders, keepers, slaughterhouse staff… –Obligation to notify to the competent authorities and investigate the suspected presence of any TSE in any animal species –Native-born animals showing clinical TSE-like signs plus high-risk categories: animals from countries with indigenous TSE, animals consuming potentially contaminated feedstuffs, and animals with TSE-infected parents –Report to the EU Standing Veterinary Committee

Minimum number based on population size Initial minimum number of clinical suspects investigated 100,000 (cattle >20 m.o.a. or SR > 10m.o.a.) – 10 tested 40, (cattle >20 m.o.a. or SR > 10m.o.a.) – 433 tested Regulation 999/2001/EC: any animal suspected of being infected by a TSE: under restriction until results of clinical and epidemiological examination Tested using a rapid screening and confirmatory tests by approved laboratories by National Reference Lab. Integrating TSE passive surveillance

Integration: Reg. 999/2001/EC Until July 2001: passive epidemio-surveillance for TSEs and limited active surveillance for BSE Need for a comprehensive active surveillance system for BSE and scrapie Objective: The purpose of the TSE surveillance in the EU is mainly to monitor the BSE epidemic, not to detect new cases. Integration all measures for the prevention, control and eradication of TSE.

Integration: Reg. 999/2001/EC “The TSE Regulation”: framework for all measures related to the monitoring, prevention and control of TSE in the EU: –notification of clinical suspects –monitoring of animal TSE –feed ban, –SRM removal –movement restrictions and other measures for suspect and confirmed cases –Intra-community trade –placing on the market of animal products and export –Reference labs, sampling and testing After many subsequent amendments, still in force today

BSE: surveillance streams in cattle Cattle slaughtered for human consumption (SHC) Initial quotas of SHC + NSHC + emergency slaughter based on cattle populations - 100,000 – 950 animals tested - 12, – 13,500 animals tested Quota based on age of cattle at slaughter: –> 30 m.o.a. For certain MSs possible derogation up to 48 m.o.a. –> 48 m.o.a. From 1 January 2009 (Decision 2008/908/EC) –> 72 m.o.a. from 1 July 2011 (Decision 2011/358/EC) –discontinued from 1 January 2013 Regulation 2245/2003/EC: all SHC tested Amendments if MS which can demonstrate improvement of the BSE situation (Regulation 571/2008/EC)

BSE: surveillance streams in cattle At-risk animals Cattle not slaughtered for human consumption (NSHC) Fallen stock. Quota based on age of cattle at death. –> 30 m.o.a. Regulation 999/2001/EC –> 24 m.o.a. (48m). Derogations. Regulation 1248/2001/EC –> 48 m.o.a. (2009) but >24 if not from one of 17 MSs Regulation 2245/2003/EC: all NSHC tested

BSE: surveillance streams in cattle At-risk animals Special emergency slaughter: for certain MSs possible derogation up to 48 m.o.a. –From January to June 2001: all animals over 30 months of age –From July to December 2001: all animals over 24 months of age Animals with clinical signs at AM inspection: > 24 m.o.a. For certain MSs possible derogation up to 48 m.o.a. BSE eradication measures: feed cohorts: all cattle one year +/- raised with BSE case

Scrapie: surveillance streams in SR S&G slaughtered for human consumption (SHC) Quota based on population. Testing of SR >18 m.o.a. or more than two permanent incisor teeth Initial quotas based on population (Reg.1248/2001/EC): 5,000 – 4750 animals tested > – animals tested “If population of ewes put to the ram / goats which have already kidded or mated exceeds 750,000 animals – min. 10,000” (Regulation 2245/2003/EC) All animals > 18 months in MS with minor populations

Scrapie: surveillance streams in SR S&G not slaughtered for human consumption (NSHC) Fallen Stock. Quota based on population. Testing of SR >18 m.o.a. or more than two permanent incisor teeth. Regulation 2245/2003/EC and Regulation 727/2007/EC Ewe populationMinimum sample size Goat populationMinimum sample size >750,00010,000>750,0005,000 >250, ,0001,500>100, ,0001,500 40, , % up to 50040, , % up to 500 <40, % up to 100< % up to 50

Integration: Reg. 999/2001/EC: amendments Survey of prion protein genotypes of sheep breeds (Decision 2002/1003/EC) Increased monitoring in goats: first natural BSE case in a goat in France (Regulation 214/2005/EC) Mandatory discriminatory testing for BSE of TSE cases detected in SR (Regulation 36/2005/EC). Only MSs with major ovine/caprine population must test SHC in SR from 1 July 2007 (Regulation 727/2007/EC): 10,000 if population >750,000

Surveillance of Chronic wasting disease (CWD) Emergence of CWD in the USA led the EC to investigate the presence of the disease in MS A survey for chronic wasting disease (CWD) in cervids was carried out during Decision 2007/182/EC). No positive cases were found. TSE Regulation includes a provision requiring the examination of TSE suspicion in all animal species. Active monitoring in species other than bovine, ovine, caprine and cervid animals is voluntary

Summary Evolution of the legal framework of TSE surveillance along new scientific knowledge Initial control and prevention focused on BSE Notifiable disease status for TSEs: EU level and national legislation. Implications for detection and control. Passive surveillance Reg. 999/2001/EC: integration of surveillance streams and prevention and control

Summary Active surveillance still in place with subsequent multiple amendments. Reduction of testing number of animals Epidemiological assessment of the diseases. Monitor trends. Not specifically to detect new cases Due to changes in prevalence and diminishing risk to public health, relaxation in surveillance efforts. Watch out this space